COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Genetics and Molecular Research · 2026 · 25 (1s)
DOI: 10.4238/e91xh631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, 2026. Verfasst von Mahvash Khan und 5 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khan, M., Malik, M. O., Sajjad, S., Uzair, M., Shah, I., & Bhatti, M. I. (2026). COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Genetics and Molecular Research, 25(1s). https://doi.org/10.4238/e91xh631
Vancouver
Khan M, Malik MO, Sajjad S, Uzair M, Shah I, Bhatti MI. COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Genetics and Molecular Research. 2026;25(1s). doi:10.4238/e91xh631
BibTeX
@article{Khan2026,
author = {Khan, Mahvash and Malik, Muhammad Omar and Sajjad, Sara and Uzair, Muhammad and Shah, Inayat and Bhatti, Muhammad Ismail},
title = {COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER},
journal = {Genetics and Molecular Research},
year = {2026},
volume = {25},
number = {1s},
doi = {10.4238/e91xh631}
}
EUVIMED